JNCCN-360

Editor:

James L. Mohler, MD

Advertisement

Advertisement

Charles von Gunten, MD, PhD, on Protecting Opioid Access: NCCN Guideline Recommendations

Nicholas D. James, PhD, MBBS, on Prostate Cancer: STAMPEDE Trial Results and NCCN Guidelines

Jeremy Warner, MD, on Patient Navigation: The Proactive Approach

Recent

Cyclohexanone Curcumin Analogs May Hinder Progression of Castration-Resistant Prostate Cancer

Predicting Aggressive Prostate Cancer in Black Men

NICE Recommends Noninvasive MRI Screening for Prostate Cancer

Clinical Practice Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer

Published

Medical Literature

Does Apalutamide Negatively Impact Quality of Life in Nonmetastatic CRPC?

AUA Guideline Amendment for Castration-Resistant Prostate Cancer

Closer Look at Types of Prostatectomy and Quality of Life

Does Androgen-Deprivation Therapy Increase Risk of Heart Failure in Men With Prostate Cancer?

Ongoing

Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers

New Directions in Nonmetastatic CRPC: Perspectives on the Latest Data (login required)

Metastatic CRPC: Clinical Strategies (login required)

Prostate Cancer Patient Management Simulator

Available

Clinical Trials

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Helen Diller Family Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center

Dana-Farber Cancer Institute

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.